New Targeted Radiopharmaceutical Therapy Achieves Remission in Pancreatic Cancer Model
A groundbreaking advancement in the field of targeted radiopharmaceutical therapy heralds a new era for treating pancreatic ductal adenocarcinoma (PDAC), ...
A groundbreaking advancement in the field of targeted radiopharmaceutical therapy heralds a new era for treating pancreatic ductal adenocarcinoma (PDAC), ...
In the relentless battle against pancreatic ductal adenocarcinoma (PDAC), a notoriously aggressive and treatment-resistant cancer, researchers have uncovered a groundbreaking ...
PHOENIX, Ariz. — April 30, 2025 — HonorHealth Research Institute’s new downtown Phoenix laboratory has produced its first study, centered ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine